158 related articles for article (PubMed ID: 12110091)
1. Involvement of adrenomedullin induced by hypoxia in angiogenesis in human renal cell carcinoma.
Fujita Y; Mimata H; Nasu N; Nomura T; Nomura Y; Nakagawa M
Int J Urol; 2002 Jun; 9(6):285-95. PubMed ID: 12110091
[TBL] [Abstract][Full Text] [Related]
2. Regulation of vascular endothelial growth factor transcription by endothelial PAS domain protein 1 (EPAS1) and possible involvement of EPAS1 in the angiogenesis of renal cell carcinoma.
Xia G; Kageyama Y; Hayashi T; Kawakami S; Yoshida M; Kihara K
Cancer; 2001 Apr; 91(8):1429-36. PubMed ID: 11301389
[TBL] [Abstract][Full Text] [Related]
3. Comparative analysis of COX-2, vascular endothelial growth factor and microvessel density in human renal cell carcinomas.
Hemmerlein B; Galuschka L; Putzer N; Zischkau S; Heuser M
Histopathology; 2004 Dec; 45(6):603-11. PubMed ID: 15569051
[TBL] [Abstract][Full Text] [Related]
4. Tissue expression and plasma levels of adrenomedullin in renal cancer patients.
Michelsen J; Thiesson H; Walter S; Ottosen PD; Skøtt O; Jensen BL
Clin Sci (Lond); 2006 Jul; 111(1):61-70. PubMed ID: 16515534
[TBL] [Abstract][Full Text] [Related]
5. Tubulogenesis by microvascular endothelial cells is mediated by vascular endothelial growth factor (VEGF) in renal cell carcinoma.
Nakagawa M; Emoto A; Hanada T; Nasu N; Nomura Y
Br J Urol; 1997 May; 79(5):681-7. PubMed ID: 9158500
[TBL] [Abstract][Full Text] [Related]
6. High-grade clear cell renal cell carcinoma has a higher angiogenic activity than low-grade renal cell carcinoma based on histomorphological quantification and qRT-PCR mRNA expression profile.
Baldewijns MM; Thijssen VL; Van den Eynden GG; Van Laere SJ; Bluekens AM; Roskams T; van Poppel H; De Bruïne AP; Griffioen AW; Vermeulen PB
Br J Cancer; 2007 Jun; 96(12):1888-95. PubMed ID: 17505508
[TBL] [Abstract][Full Text] [Related]
7. Correlation of vascular endothelial growth factor and hypoxia-inducible factor-1α expression with pathological renal artery changes in patients with renal cell carcinoma.
Demirović A; Tomas D; Tomić K; Spajić B; Ibukić A; Cupić H; Krušlin B
Scand J Urol; 2014 Feb; 48(1):34-40. PubMed ID: 24256617
[TBL] [Abstract][Full Text] [Related]
8. Angiogenesis in renal cell carcinoma: Evaluation of microvessel density, vascular endothelial growth factor and matrix metalloproteinases.
Zhang X; Yamashita M; Uetsuki H; Kakehi Y
Int J Urol; 2002 Sep; 9(9):509-14. PubMed ID: 12410931
[TBL] [Abstract][Full Text] [Related]
9. Novel mechanism of action for hydralazine: induction of hypoxia-inducible factor-1alpha, vascular endothelial growth factor, and angiogenesis by inhibition of prolyl hydroxylases.
Knowles HJ; Tian YM; Mole DR; Harris AL
Circ Res; 2004 Jul; 95(2):162-9. PubMed ID: 15192023
[TBL] [Abstract][Full Text] [Related]
10. Expression and role of adrenomedullin in renal tumors and value of its mRNA levels as prognostic factor in clear-cell renal carcinoma.
Deville JL; Bartoli C; Berenguer C; Fernandez-Sauze S; Kaafarani I; Delfino C; Fina F; Salas S; Muracciole X; Mancini J; Lechevallier E; Martin PM; Figarella-Branger D; Ouafik L; Daniel L
Int J Cancer; 2009 Nov; 125(10):2307-15. PubMed ID: 19610056
[TBL] [Abstract][Full Text] [Related]
11. EMMPRIN promotes angiogenesis, proliferation, invasion and resistance to sunitinib in renal cell carcinoma, and its level predicts patient outcome.
Sato M; Nakai Y; Nakata W; Yoshida T; Hatano K; Kawashima A; Fujita K; Uemura M; Takayama H; Nonomura N
PLoS One; 2013; 8(9):e74313. PubMed ID: 24073208
[TBL] [Abstract][Full Text] [Related]
12. [Relationship between expression of matrix metalloproteinase-9 (MMP-9) and angiogenesis in renal cell carcinoma].
Zhang Y; Wu XH; Cao GH; Li S
Ai Zheng; 2004 Mar; 23(3):326-9. PubMed ID: 15025968
[TBL] [Abstract][Full Text] [Related]
13. Different vascular endothelial growth factor (VEGF), VEGF-receptor 1 and -2 mRNA expression profiles between clear cell and papillary renal cell carcinoma.
Ljungberg BJ; Jacobsen J; Rudolfsson SH; Lindh G; Grankvist K; Rasmuson T
BJU Int; 2006 Sep; 98(3):661-7. PubMed ID: 16925769
[TBL] [Abstract][Full Text] [Related]
14. Renal cancer cells lacking hypoxia inducible factor (HIF)-1alpha expression maintain vascular endothelial growth factor expression through HIF-2alpha.
Shinojima T; Oya M; Takayanagi A; Mizuno R; Shimizu N; Murai M
Carcinogenesis; 2007 Mar; 28(3):529-36. PubMed ID: 16920734
[TBL] [Abstract][Full Text] [Related]
15. Up-regulation of hypoxia-inducible factor 2alpha in renal cell carcinoma associated with loss of Tsc-2 tumor suppressor gene.
Liu MY; Poellinger L; Walker CL
Cancer Res; 2003 May; 63(10):2675-80. PubMed ID: 12750296
[TBL] [Abstract][Full Text] [Related]
16. Expression of Ets-1 in human clear cell renal cell carcinomas: implications for angiogenesis.
Mikami S; Oya M; Mizuno R; Murai M; Mukai M; Okada Y
Cancer Sci; 2006 Sep; 97(9):875-82. PubMed ID: 16856880
[TBL] [Abstract][Full Text] [Related]
17. Hypoxia-inducible factor-1 (HIF-1) up-regulates adrenomedullin expression in human tumor cell lines during oxygen deprivation: a possible promotion mechanism of carcinogenesis.
Garayoa M; Martínez A; Lee S; Pío R; An WG; Neckers L; Trepel J; Montuenga LM; Ryan H; Johnson R; Gassmann M; Cuttitta F
Mol Endocrinol; 2000 Jun; 14(6):848-62. PubMed ID: 10847587
[TBL] [Abstract][Full Text] [Related]
18. The relationship of vascular endothelial growth factor and coagulation factor (fibrin and fibrinogen) expression in clear cell renal cell carcinoma.
Verheul HM; van Erp K; Homs MY; Yoon GS; van der Groep P; Rogers C; Hansel DE; Netto GJ; Pili R
Urology; 2010 Mar; 75(3):608-14. PubMed ID: 19683801
[TBL] [Abstract][Full Text] [Related]
19. Adrenomedullin antagonist suppresses tumor formation in renal cell carcinoma through inhibitory effects on tumor endothelial cells and endothelial progenitor mobilization.
Tsuchiya K; Hida K; Hida Y; Muraki C; Ohga N; Akino T; Kondo T; Miseki T; Nakagawa K; Shindoh M; Harabayashi T; Shinohara N; Nonomura K; Kobayashi M
Int J Oncol; 2010 Jun; 36(6):1379-86. PubMed ID: 20428760
[TBL] [Abstract][Full Text] [Related]
20. Angiogenesis in renal cell carcinoma: the role of tumor-associated macrophages.
Toge H; Inagaki T; Kojimoto Y; Shinka T; Hara I
Int J Urol; 2009 Oct; 16(10):801-7. PubMed ID: 19811548
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
